Page results
-
This page explains how to hand express your colostrum. It is for mothers/birthing parents who will have a baby on the neonatal unit.
-
This service caters for babies, children and adolescents (attending the AVM and ENT departments at the Royal National ENT & Eastman Dental Hospitals) with congenital or acquired deafness or auditory processing disorders. The service provides assessment and advice only.
-
Whether to check appointment details, receive test results and clinic letters, or to complete pre-visit questions and checks to prepare for appointments, more and more patients activate MyCare UCLH each day.
-
This patient information explains what Aural (ear) microsuction is and what your alternatives are.
-
This has been written by the acupuncture team at the Royal London Hospital for Integrated Medicine ( It gives you information about how to do home- acupuncture and how to manage any possible side effects.
-
This page explains how to start using a breast pump.
-
Using Attend Anywhere for video clinics You and your clinician are able to communicate over a secure online video system called Attend Anywhere. What do I need to make an Attend Anywhere video…
-
Johanna Moss was appointed to the Board on 7 January 2025 as the director of strategy. Prior to this Jo was the chief strategy and transformation officer for the North East London Integrated Care Board and she also held the role of director of strategy and partnerships at Moorfields Eye Hospital NHS Foundation Trust for seven years, where she was the lead for their major capital project to build a new hospital and research centre in Camden.
-
This page is for parents, carers and relatives whose child is having radiotherapy treatment to the eye (orbit). There are different conditions that may require radiotherapy to the eye such as retinoblastoma, orbital rhabdomyosarcomas, soft tissue sarcomas, lymphomas, or some other condition.
-
Adding the hormone therapy abiraterone to the standard treatment for locally advanced prostate cancer, where the cancer has a high chance of spreading, could halve the risk of death, according to the results of a trial at UCLH and UCL.
File results
-
FOI/2022/0549 - SACT (systemic anti-cancer therapy) /cervical cancer treatments
-
FOI/2022/0550 - Patients that have been treated for glioblastoma brain cancer
-
FOI/2022/0553 - Patients tested for non-small cell lung cancer biomarkers
-
FOI/2022/0561 - Regulation (EU) 2016/425 Declarations of Conformity for all type IIR surgical masks provided as PPE to staff
-
FOI/2022/0571 - Treatment for biologic medicines in Dermatology
-
FOI/2022/0572 - Treatments for Hidradenitis Suppurativa and Psoriasis
-
FOI/2022/0573 - Use of WhatsApp by or within the Trust
-
FOI/2022/0513 - Myelofibrosis treatment
-
FOI/2022/0540 - Electronic patient record
-
FOI/2022/0541 - Serious Incidents Level 2 deaths/ serious harm